RachelElizabethRaabMD

Oncology • Asheville, NC

Physician

Join to view full profile

Dr. Raab is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Raab's full profile

Already have an account?

Office
551 Brevard Road
Asheville, NC 28806
Phone+1 828-212-7021

Fax+1 828-670-8404
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2005 - 2008
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2005
University of Vermont Medical CenterInternship, Internal Medicine, 2002 - 2003
Brody School of Medicine at East Carolina UniversityClass of 2002

Certifications & Licensure

NC State Medical License 2008 - 2025
NY State Medical License 2005 - 2010
VT State Medical License 2002 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Registry of Older Patients With Cancer Start of enrollment: 2009 Sep 01
Recruiting
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Start of enrollment: 2011 Feb 01
Withdrawn

Publications & Presentations

PubMed

2 citations
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A.
Rachel Raab, Nofisat Ismaila, Fabrice Andre, Vered Stearns, Kevin Kalinsky> ;JCO Oncology Practice. 2022 Sep 1
102 citations
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.
Fabrice Andre, Nofisat Ismaila, Kimberly H Allison, William E Barlow, Deborah E Collyar, Senthil Damodaran, N Lynn Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M Kuder...> ;Journal of Clinical Oncology. 2022 Jun 1
83 citations
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
Kala Visvanathan, Carol J. Fabian, Elissa T. Bantug, Abenaa M. Brewster, Nancy E. Davidson, Andrea Decensi, Justin D. Floyd, Judy Garber, E Hofstatter, Seema A. Khan, ...> ;Journal of Clinical Oncology. 2019 Sep 3
5 citations
Implementing a personalized medicine cancer program in a community cancer system.
Lynn G. Dressler, Gillian C. Bell, David P Schuetze, Mark R Steciuk, Oliver A Binns, Rachel E Raab, Pearl M Abernathy, Carolyn M Wilson, Sedope E Kunutsor, Marika C Lo...> ;Personalized Medicine. 2019 May 1
37 citations
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity
Daniel L. Hertz, Allison M. Deal, Joseph G. Ibrahim, Christine M. Walko, Karen E. Weck, Steven M. Anderson, Gustav Magrinat, Oludamilola Olajide, Susan E. Moore, Rache...> ;The Oncologist. 2016 Jul 1
39 citations
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
Daniel L. Hertz, Anna C. Snavely, Howard L. McLeod, Christine M. Walko, Joseph G. Ibrahim, Steven M. Anderson, Karen E. Weck, Gustav Magrinat, Oludamilola Olajide, Sus...> ;British Journal of Clinical Pharmacology. 2015 Nov 1
32 citations
Patient Navigation and the Quality of Breast Cancer Care: An Analysis of the Breast Cancer Care Quality Indicators
Joseph J. Weber, Debra C. Mascarenhas, Lisa S. Bellin, Rachel Elizabeth Raab, Jan H. Wong> ;Annals of Surgical Oncology. 2012 Jul 20
95 citations
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer
Lijun Di, Jung S. Byun, Madeline M. Wong, Clay Wakano, Tara J. Taylor, Sven Bilke, Songjoon Baek, Kent W. Hunter, Howard H. Yang, Maxwell P. Lee, Cecilia Zvosec, Galin...> ;Nature Communications. 2013 Feb 5
A pilot study of the decision-making process of seeking medical care in women diagnosed with large breast tumors.
Eggar JM, Lea CS, Bellin LS, Raab RE, Wong JH, Burke LP> ;J. Clin. Oncol.. 2011-09-20
131 citations
Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
William J. Irvin, Christine M. Walko, Karen E. Weck, Joseph G. Ibrahim, Wing Keung Chiu, E. Claire Dees, Susan G. Moore, Oludamilola Olajide, Mark L. Graham, Sean Thom...> ;Journal of Clinical Oncology. 2011 Aug 20
A pilot study of tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy.
Raab RE, Pawlowski TL, Spetzler D, Klass MR, Kuslich CD, Bellin LS, Wong JH, Asch AS> ;J. Clin. Oncol.. 2011-05-20
Comprehensive CYP2D6 genotyping in a multiracial population shows differences in allele frequencies between races.
Irvin WJ, Weck KE, Walko CM, Chiu WK, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Anderson SM, Friedman KJ, Dees EC, Flockhart D, Peppe...> ;J. Clin. Oncol.. 2011-05-20
Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer.
Brewer NT, Walko CM, Chiu WK, Dressler LG, Yuen A, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL, Carey LA, Irvi...> ;J. Clin. Oncol.. 2011-05-20
The East Carolina Breast Center phase II trial of neoadjuvant metronomic chemotherapy in triple-negative breast cancer.
Raab RE, Walker PR, Bellin LS, Wong JH> ;J. Clin. Oncol.. 2011-05-20
Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
Trautwein C, Possienke M, Schlitt HJ, Böker KH, Horn R, Raab R, Manns MP, Brabant G> ;Am. J. Gastroenterol.. 2000-09-01
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma.
Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C, Tusch G, Raab R> ;Br J Surg. 2000-09-01
Long-term experience after ex situ liver surgery.
Oldhafer KJ, Lang H, Schlitt HJ, Hauss J, Raab R, Klempnauer J, Pichlmayr R> ;Surgery. 2000-05-01
Ex-vivo resection techniques in tissue-preserving surgery for liver malignancies.
Raab R, Schlitt HJ, Oldhafer KJ, Bornscheuer A, Lang H, Pichlmayr R> ;Langenbecks Arch Surg. 2000-04-01
Attitudes of patients before and after transplantation towards various allografts.
Schlitt HJ, Brunkhorst R, Schmidt HH, Nashan B, Haverich A, Raab R> ;Transplantation. 1999-08-27
Attitude of patients toward transplantation of xenogeneic organs.
Schlitt HJ, Brunkhorst R, Haverich A, Raab R> ;Langenbecks Arch Surg. 1999-08-01
Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H, Schlitt HJ, Schmidt H, Flemming P, Nashan B, Scheumann GF, Oldhafer KJ, Manns MP, Raab R> ;Langenbecks Arch Surg. 1999-08-01
Rescue hepatectomy for initial graft non-function after liver transplantation.
Oldhafer KJ, Bornscheuer A, Frühauf NR, Frerker MK, Schlitt HJ, Ringe B, Raab R, Pichlmayr R> ;Transplantation. 1999-04-15
Peripheral hepatojejunostomy as palliative treatment for irresectable malignant tumors of the liver hilum.
Schlitt HJ, Weimann A, Klempnauer J, Oldhafer KJ, Nashan B, Raab R, Pichlmayr R> ;Ann. Surg.. 1999-02-01
Is liver transplantation superior to resection in early stage hepatocellular carcinoma?
Weimann A, Schlitt HJ, Oldhafer KJ, Hoberg S, Tusch G, Raab R> ;Transplant. Proc.. 1999-01-01
Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation.
Schlitt HJ, Meier PN, Nashan B, Oldhafer KJ, Boeker K, Flemming P, Raab R, Manns MP, Pichlmayr R> ;Ann. Surg.. 1999-01-01
Join now to see all

Hospital Affiliations

Mission HospitalAsheville, North Carolina